MOSCOW (MRC) -- Solvay has started production at its two new large-scale and "on-pipe" alkoxylation facilities in Moerdijk, the Netherlands, and in Singapore, said the company in its press release.
Both units are located in integrated petrochemical hubs and receive ethylene oxide via dedicated pipelines, providing a secure supply of this key raw material for a wide range of specialty surfactants by Solvay’s Novecare business.
"In the Netherlands, our teams were able to start production well ahead of schedule to meet the evolving regional supply needs of our customers," said Emmanuel Butstraen, President of Solvay’s Novecare Global Business Unit.
"Both facilities in Moerdijk and in Singapore are platforms for providing highly competitive and innovative intermediates to further penetrate key markets in Europe and Asia Pacific for our agrochemicals, coatings, home and personal care, industrial and oil and gas markets."
At its recently acquired Moerdijk site, situated between the key regional transport and logistics hubs of Rotterdam, the Netherlands, and Antwerp, Belgium, Solvay is ramping up capacity already for the third quarter.
The Novecare plant in Singapore will hold its opening ceremony next month. It is ramping up full-scale production after having successfully completed its trial batch production in May. Solvay’s Novecare is already Asia’s largest specialty surfactant manufacturer with 10 production sites, two Research & Innovation centers in Singapore and Shanghai, China, and a recently opened R&I laboratory in Tokyo, Japan.
Both facilities produce alkoxylates which form the chemical foundation for a broad offering of Novecare’s specialty surfactants, which are used for example in shampoos, detergents, paints, lubricants and plant protection.
As MRC informed earlier, Solvay and INEOS received final approval today from the European Commission to form their 50/50 Chlorvinyls Joint Venture, to be known as INOVYN. This follows Commission approval of International Chemical Investors Group’s (ICIG) acquisition of the remedy business that is being divested by INEOS as a condition of clearance.
Solvay S.A. is a Belgian chemical company founded in 1863, with its head office in Neder-Over-Heembeek, Brussels, Belgium. The company has diversified into two major sectors of activity: chemicals and plastics. Solvay supplies over 1500 products across 35 brands of high-performance polymers – fluoropolymers, fluoroelastomers, fluorinated fluids, semi-aromatic polyamides, sulfone polymers, aromatic ultra polymers, high-barrier polymers and cross-linked high-performance compounds.
MRC